Vera Therapeutics CEO Fordyce Marshall disposes of USD 684,500 in common shares

• Vera Therapeutics President and CEO Marshall Fordyce exercised stock options for 18,500 Class A shares at $2.9.
• He sold 18,500 Class A shares at $37 in the same filing.
• Direct Class A holdings fell to 235,244 shares.
• Stock options beneficially owned rose to 488,801 following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001859453-26-000015), on September 17, 2026, and is solely responsible for the information contained therein.